期刊文献+

LyGDI对肺癌A549细胞放射敏感性影响的观察 被引量:1

Effects of LyGDI on radiosensetivity in A549 cells
原文传递
导出
摘要 目的:研究X射线对稳定转染鸟苷解离抑制因子(LyGDI)A549细胞株放射敏感性的影响及相关机制。方法:应用生长曲线观察细胞增殖能力,流式细胞术检测不同剂量照射后转染组和对照组细胞的周期分布及凋亡率,克隆形成试验观察转染组细胞放射敏感性。结果:转染组细胞相对于对照组增殖能力减弱,F=212.55,P<0.01;克隆形成能力减弱,放射敏感性增加,F=7.56,P<0.05;流式细胞术检测到辐射诱导凋亡增加,F=18.45,P<0.01;细胞周期检测提示转染组G2期阻滞受抑制,F=6.29,P<0.05。结论:过度表达的LyGDI上调A549细胞放射敏感性,其可能机制为抑制G2期阻滞促进凋亡。 OBJECTIVE:To investigate the effect of X-ray on radiosensetivity in A549 cell line of stable transfected with LyGDI and the relative mechanism.METHODS: Growth curve was used to measure changes of cell proliferation.Flow cytometry was used to determine cell cycle distribution and apoptotic cell rate.Clony formation assay was used to measure radiosensetivity of the A549 with different phenotypes.RESULTS: The cell line of stable transfected with LyGDI got a lower proliferation(F=212.55,P0.01) and survival rate(F=7.56,P0.05) after irradiation with different doses of X-ray compared with control cell line.Radiation-induced G2 arrest was abrogated in A549-LyGDI cell line(F=6.29,P0.05) and the apoptosis induced by X-irradiation in A549-LyGDI line was enhanced(F=18.45,P0.01).CONCLUSIONS: It showed that LyGDI induced cell apoptosis upgraded sensitivity to radiation in A549 cell line.Abrogation of radiation-induced G2 arrest can be part of the mechanism.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第2期84-87,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30570548)
关键词 肺肿瘤/放射疗法 细胞周期 辐射耐受性 lung neoplasms/radiotherapy cell cycle distribution radiation tolerance
  • 相关文献

参考文献15

  • 1Zhang B.RhoGDP dissociation inhibitors as potential targets for anti-cancer treatment[J].Drug Resist Updat,2006,9(3):134-141.
  • 2董玉金,吴纪霞,王兴丹,曹丽丽,韩琴芳,周新文.LyGDI真核表达载体构建及稳定转染A549细胞株的建立[J].苏州大学学报(医学版),2009,29(1):108-111. 被引量:1
  • 3Etienne-Manneville S,Hall A.RhoGTPases in cell biology[J].Na-ture,2002,420(6916):629-635.
  • 4Leffers H,Nielsen MS,Andersen AH,et al.Identification oftwo human RhoGDP dissociation inhibitor proteins whose over-expression leads to disruption of the actin cytoskeleton[J].ExpCell Res,1993,209(2):165-174.
  • 5Zhou X,Suto S,Ota T,et al.Nuclear translocation of cleaved LyGDIdissociated from rho and roC during p53-dependent ionizing radiation-induced thymic apoptosis in vitro[J].Radiat Res,2004,162(3):287-295.
  • 6Zhang Y,Zhang B.D4-GDI,a Rho GTPase regulator,promotesbreast cancer cell invasiveness[J].Cancer Res,2006,66(11):5592-5598.
  • 7Cho HJ,Baek KE,Park SM,et al.RhoGDI2expression is as-sociated with tumor growth and malignant progression of gastriccancer[J].Human Cancer Biology,2009,15(8):2612-2619.
  • 8Hu LD,Zou HF,Zhan SX,et al.Biphasic expression of RhoGDI2inthe progression of breast cancer and its negative relation with lymphnode metastasis[J].Oncol Rep,2007,17(6):1383-1389.
  • 9Michael AH,Dan T.RhoGDI2:a new metastasis suppressor gene:discovery and clinical translation[J].Urologic Oncology,2007,25(5):401-406.
  • 10Matthew DN,Michael AH,Dan T.Invasion and metastasis modelsfor studying rhoGDI2in bladder cancer[J].Methods in Enzymology,2008,439:219-233.

二级参考文献58

  • 1王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:626
  • 2周新文.辐射诱导小鼠淋巴瘤细胞凋亡涉及NADPH氧化酶的活性[J].细胞生物学杂志,2006,28(3):468-472. 被引量:3
  • 3周新文,许雅香.lyGDI在HeLa细胞中的表达与辐射增敏研究[J].中华放射医学与防护杂志,2006,26(6):554-556. 被引量:4
  • 4Kurman RJ, Visvanathan K, Roden R, et al. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis [ J]. Am J Obstet Gynecol 198 (2008) 351-356.
  • 5Jr Bast RC, Klug TL, St JE, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer [J]. N Engl J Med 309 (1983): 883-887.
  • 6Fritsche HA, Bast RC. CA 125 in ovarian cancer: advances and controversy [J]. Clin Chem , 1998, 44 : 1379-1380.
  • 7Zhang Z, Barnhill SD, Zhang H, et al. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses [ J]. Gynecol Oncol 73 (1999) 56-61.
  • 8Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers [ J ]. JAMA, 1998, 280: 719-723.
  • 9Dupont J, Tanwar MK, Thaler HT, et al. Early detection and prognosis of ovarian cancer using serum YKL-40 [ J ]. J Clin Oncol 2004, 22: 3330-3339.
  • 10Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol [ J], 2005, 21: 247-269.

共引文献17

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部